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Serine proteaseRhomboid proteases are a family of integral membrane proteins that have been implicated in critical regula-
tory roles in a wide array of cellular processes and signaling events. The determination of crystal structures of
the prokaryotic rhomboid GlpG from Escherichia coli and Haemophilus inﬂuenzae has ushered in an era of
unprecedented understanding into molecular aspects of intramembrane proteolysis by this fascinating
class of protein. A combination of structural studies by X-ray crystallography, and biophysical and spectro-
scopic analyses, combined with traditional enzymatic and functional analysis has revealed fundamental
aspects of rhomboid structure, substrate recognition and the catalytic mechanism. This review summarizes
these remarkable advances by examining evidence for the proposed catalytic mechanism derived from inhib-
itor co-crystal structures, conﬂicting models of rhomboid-substrate interaction, and recent work on the struc-
ture and function of rhomboid cytosolic domains. In addition to exploring progress on aspects of rhomboid
structure, areas for future research and unaddressed questions are emphasized and highlighted. This article
is part of a Special Issue entitled: Intramembrane Proteases.
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Proteolytic processing of proteins for regulatory purposes is a
pervasive and tightly controlled mechanism for regulation of cellular
activity. Over the past ﬁfteen years it has become increasingly apparent
Fig. 1. Structure of the rhomboid core of ecGlpG. (A) Structure and topology of E. coliGlpG
(ecGlpG, PDB ID: 2IC8), composed of six transmembrane helices (TM) (1–6). A long hair-
pin loop connects TM1 and TM2 (L1, yellow), catalytic residues are found on TM2 and
TM4. Substrate entry gate is though to be composed of TM5 (blue) or the loop connecting
TM5 and TM6 (L5, “cap”, red). (B) Top view of the ecGlpG active site, the L5 cap (red)
blocks access of substrate to the catalytic residues, His254 and Ser201.
Table 1
Structures of rhomboid GlpG.
Structure PDB ID Space group Reference
Native Apo structures
ecGlpG native 2IC8 R32 [9]
ecGlpG native 2IRV P21 [11]
ecGlpG native 2XOV R32 [14]
ecGlpG native 3B45 R32 [13]
hiGlpG native 2NR9 C2 [18]
ecGlpG open cap structure 2O7L R32 [12]
Lateral gate open structures
ecGlpG 2NRF P31 [10]
hiGlpG (TM5 disordered) 3ODJ C2 [19]
Mutant structures
L1 mutant W136A 3B44 R32 [13]
Mutant S201T (bicelle) 2XTV P212121 [15]
Mutant S201T (detergent) 2XTU R32 [15]
Inhibitor structures
ecGlpG: DFP 3TXT R32 [16]
ecGlpG: isocoumarin 2XOW R32 [14]
ecGlpG: CAPF 3UBB R32 [17]
Cytoplasmic domains
paGlpG (NMR structure) 2GQC N/A [24]
ecGlpG (NMR structure) 2LEP N/A [25]
ecGlpG (X-ray structure) 4HDD I422 [26]
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cellular signaling events [1,2]. The proteolytic processing of membrane
bound substrates to release soluble ligands that can interact with other
receptors represents an elegant and simple mechanism for controlling
signaling events.
The rhomboid family of intramembrane proteases (peptidases) is
amongst the best understood class of membrane protease, having
an ever increasing number of physiological roles assigned to them,
as well as detailed structural and functional analysis. The initial
discovery of the rhomboid class of protease emerged from classical
Drosophila genetic studies where mutations in the gene resulted in a
rhomboid-shaped head in the developing embryo [3]. The protein
product of the rhomboid gene was found to play a role in epidermal
growth factor receptor (EGFR) signaling, and it was conclusively
demonstrated that Rhomboid-1 was a membrane bound protease
that cleaved and liberated the soluble EGF domain of the substrate
Spitz [4].
One of the most highly conserved families of membrane proteins,
rhomboids have been found in all three domains of life [5]. However,
despite their near ubiquitous presence, it is important to note that
they have not been found in all species, such as parasites with small
genomes and some Archaea [5]. The wide phylogenetic distribution
does however suggest that rhomboid catalyzed proteolysis is a
well-conserved regulatory mechanism employed by all types of
organisms. Indeed, dizzying arrays of functions have been attributed
to rhomboids, ranging from quorum sensing, mitochondrial fusion,
parasitic invasion, protein quality control and many others that
have been reviewed extensively elsewhere [1,2,6,7].
Since their initial description, rhomboids have rapidly become the
paradigm for understanding not only the diversity of roles that
intramembrane proteolysis plays, but have also provided an unprece-
dented gaze at the atomic details of proteolysis in a membrane envi-
ronment. This review aims to explore recent insights into the
structure–function relationship of rhomboid proteases that has been
revealed by several X-ray crystal structures, NMR structures, molecu-
lar dynamics simulations and biophysical analyses. In particular, we
focus on the recent advances in understanding the catalytic mecha-
nism from inhibitor bound structures, the interaction of rhomboid
with its substrates, and the recent studies that have begun to eluci-
date the importance of rhomboid accessory domains.
2. Structures and features of rhomboid proteases
2.1. Rhomboid topologies
Rhomboid proteases can be classiﬁed into three distinct topologies
[8]. The ﬁrst and simplest topology has six transmembrane (TM)
helices (Fig. 1A), and is referred to as the rhomboid catalytic core.
This minimal unit is the most prevalent topology amongst prokaryot-
ic rhomboids. To date the only crystal structures available are of this
6TM topology, with structures having been determined of the rhom-
boid GlpG from Escherichia coli (ecGlpG) [9–17] and Haemophilus
inﬂuenzae (hiGlpG) [18,19] (Table 1). The other two topological clas-
ses have an additional TM helix appended to the 6TM core, either at
the N-terminus (1 + 6TM) or C-terminal to the 6TM core (6 + 1TM).
These 7TM topologies are largely conﬁned to eukaryotic rhomboids,
although there are notable exceptions, for example the prokaryotic
rhomboids AarA from Provedencia stuartti and YqgP from Bacillus
subtilis both have a 6 + 1TM topology. This 6 + 1TM topology is
shared by non-catalytic rhomboid-like proteins (iRhoms), which have
mutations in the active site that render the enzyme inactive, and large
domains at their N-termini and between TM1 and TM2. The third topol-
ogy type (1 + 6TM) appears to be limited to rhomboids found in endo-
symbiotic organelles such as mitochondria and plastids [8]. In addition
to these general topological arrangements, rhomboids can have a varie-
ty of soluble accessory domains located at either the N or C-terminus.
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tional roles in rhomboid substrate proteolysis.
2.2. Rhomboid structural features
The near simultaneous determination of crystal structures of
detergent solubilized E. coli. and H. inﬂuenzae rhomboid GlpG (ecGlpG
and hiGlpG) by four separate groups [9–11,18] provided the ﬁrst
atomic resolution glimpse into intramembrane proteolysis and key
structural features of this class of enzyme. The rhomboid core of the
protein is composed of a six transmembrane compact helical bundles,
which is almost entirely embedded in the membrane (Fig. 1B). Unlike
most traditional serine proteases that use a catalytic triad, rhomboids
employ a catalytic dyad with a serine acting as a nucleohphile
(Ser201 in ecGlpG) and a histidine acting as the general base
(His254) to hydrolyze peptide bonds. The catalytic residues are
found on TM4 and TM6 where they lie ~10 Å below the plane of the
extracellular side of the membrane. The structural architecture of
the rhomboid catalytic site provided irrefutable evidence that rhom-
boids are true intramembrane peptidases with proteolysis occurring
within the plane of the membrane. In some structures the active
site cavity is capped by a loop connecting TM5 and TM6 (loop 5, or
the “cap”) that blocks access of substrate to the catalytic residues,
presumably functioning to protect the hydrophilic cavity from the
polar environment of the membrane (Fig. 1). The obligation for this
loop to move out of the cavity, and the requirement for substrate to
access the shielded active site has led to two competing models to
explain how this may occur and how the substrate docks with the
active site. The lateral gate hypothesis proposes that TM5 is mobile
and its displacement away from the helical bundle would displace
the blocking L5 cap and permits lateral access of the substrate
through the membrane into the active site [20]. Alternatively, the
cap alone (loop 5, L5) is displaced to permit substrate access to the
active site via the top of the enzyme [12]. These models are discussed
in detail below in Section 4.
Another interesting structural feature of rhomboid is a long loop
between TM1 and TM2 (loop 1, L1), which forms a hairpin structure
parallel to plane of the membrane (Fig. 1). This loop is partially im-
mersed in the top leaﬂet of the membrane, an interaction that is
formed from hydrophobic residues that line the lower portion of the
loop. It has been suggested that this hairpin loop functions to position
rhomboid in the correct orientation in the membrane for catalysis
[13,21]. Consistent with this hypothesis the recent crystal structure
of ecGlpG in a lipid bicelle environment found that the hydrophobic
cavity formed by the base of L1 was ﬁlled with lipid, supporting the
notion that this region interacts speciﬁcally with the membrane
[15]. The hairpin L1 loop contains a “WR” motif, which is found in
the secretase class of rhomboids [8], although the motif is not directly
involved in rhomboid activity it appears to play a critical structural
role. The arginine residue forms extensive interactions within the L1
loop providing a key structural element in the formation of the
hairpin loop. Mutation of this residue abrogates protease activity,
highlighting the key structural role L1 plays in rhomboid activity
[13,22]. The tryptophan residue, in contrast, only plays a role in the
membrane environment where it is thought to shield the arginine
side chain from the lipid bilayer [22].
Since these initial structures, recent structural work (Table 1)
including three published structures of the ecGlpG 6TM core in com-
plex with inhibitors [14,16,17], the structure of the ecGlpG TM core in
a bicelle [15], a disordered substrate gate in hiGlpG [19], two NMR
structures of N-terminal cytosolic domains of ecGlpG [23,24] and a
crystal structure of the ecGlpG cytosolic domain [25] have all revealed
important clues into grasping how this remarkable class of protease
operates at the atomic level, and how it interacts with its substrate.
Many of these structures have provided crucial insight into the rhom-
boid catalytic mechanism; including the identity of the oxyanionhole, potentially part of the substrate binding pocket as mimicked
by β-lactam, and the orientation of nucleophilic attack by the catalytic
serine.
3. Rhomboid catalytic mechanism
3.1. Features of serine protease catalysis
Rhomboid proteases are classiﬁed as serine peptidase as they use a
nucleophilic serine to hydrolyse peptide bonds of transmembrane
substrates. Thirty years ago, Blow and colleagues presented the ﬁrst
structural evidence for a serine peptidase, chymotrypsin, revealing a
conserved catalytic triad in the active site consisting of a nucleophilic
serine, a general base histidine and a general acid, aspartic acid [26].
This “classic” catalytic triad [27], is found in over 240 proteases iden-
tiﬁed in the MEROPS database [28]. In traditional serine proteases the
general acid, aspartate, hydrogen bonds with the general base, histi-
dine, orienting the Nε2 atom in the imidazole ring. The nucleophilic
attack is facilitated by proton transfer from the Oγ of serine to the
Nε2 atom in the imidazole ring of the general base. The nucleophilic
oxygen attacks the carbonyl center at a precise 107° angle, (Burgi
angle) [29]. During the relay cycle of the catalytic triad, the enzyme
and substrate pass though a tetrahedral intermediate followed by
an acyl-enzyme intermediate (Fig. 2). Again with the assistance
of histidine, water becomes nucleophilic which breaks the acyl-
enzyme intermediate forming a second tetrahedral intermediate
(Fig. 2) [27]. Even though decades of work has been conducted on
serine proteases there are still outstanding questions, such as the pro-
tonation of the general acid and base in the triad which is the focus of
several recent studies [30]. During this catalytic cycle the carbonyl
from the scissile bond becomes negatively charged (an oxyanion)
and is stabilized by the oxyanion hole, a pocket typically consisting
of residues able to hydrogen bond with the oxyanion (Fig. 2).
The oxyanion hole is an especially important feature of the active
site of serine proteases as it confers properties that greatly affect the
rate at which these enzymes cleave substrate and has therefore, been
characterized in detail in many serine proteases. The negative charge
of the oxyanion plays a key role in lowering the free energy of the
activated enzyme complex. Kinetics and co-crystal structures with
either substrates or inhibitors have contributed to our knowledge of
the oxyanion hole of many classical serine proteases. The composition
of the oxyanion hole can vary depending on the protease and thus
affect the enzyme's function [27]
3.2. The catalytic mechanism of rhomboid serine proteases
The rhomboid protease family however is not a classical serine
protease being the result of a separate evolution from soluble serine
proteases. Instead of the His-Asp-Ser triad, structural studies revealed
an active site conﬁguration consisting of a Ser-His catalytic dyad.
Other novel serine protease classes composed of a catalytic dyad
have been identiﬁed. The most similar to rhomboids is signal pepti-
dase I (SPase I) which also consists of a Ser-Lys/His dyad. This protein
has been crystallized with mechanistic inhibitors including β-lactam,
which has helped identify a substrate binding pocket and a simple
oxyanion hole comprised of only the backbone amide of the catalytic
serine [31].
Key tools to assess catalytic cycles of rhomboids and soluble
serine proteases are inhibitors. For serine proteases, various classes
of potent inhibitors exist, many of which are peptide based, that
can provide insight into acyl and tetrahedral transition interme-
diates [32]. Coumarins, aza-peptides, carbamates, aldehydes and
β-lactam are known to form acyl intermediates. Inhibitors such as
chloromethyl ketones (eg N-p-tosyl-L-phenylalanine chloromethyl
ketone, i.e. TPCK), organoboronates, organophosphonates (peptide
phosphonates) and phosphonyl ﬂuorides (diisopropyl phosphonate,
Fig. 2. Catalytic scheme for serine proteases. (A) A His residue acts as a general base removing the proton from the catalytic Ser residue making it into a potent nucleophile. Note,
most typical serine peptidases also have as Asp residue acting to orient the His residue assisting in the generation the nucleophile. The combination of the Asp-His-Ser is tradition-
ally known as the catalytic triad. The Asp residue has been omitted here more closely reﬂecting the active site in GlpG. (B) The peptide substrate undergoes a nucleophilic attack by
the activated catalytic Ser residue, where a transient tetrahedral intermediate is formed between the enzyme and the substrate. The negatively charged oxyanion is stabilized by
hydrogen binding interactions from backbone amide nitrogens and/or other positively charged polar residues. These residues come together to form an oxyanion hole. The tetra-
hedral intermediate is unstable and rapidly collapses, expelling the N-terminal portion of the substrate breaking the peptide bond. (C) The remaining product is a stable
acyl-enzyme intermediate. A water molecule is activated by the His residue and the acyl-enzyme intermediate undergoes nucleophillic attack by the activated water. (D) A second
tetrahedral intermediate is formed, again stabilized by the oxyanion hole. The intermediate rapidly collapses expelling the remainder of the peptide substrate. Red line denotes
scissile bond to be cleaved.
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some differences observed between the inhibition of rhomboid ser-
ine proteases and some classical serine protease inhibitors. An initial
study demonstrated that rhomboids are insensitive to many inhibi-
tors [33]. The general tolerance of rhomboids to traditional serine
protease inhibitors has led to the search for more speciﬁc, high afﬁn-
ity inhibitors. Recently, use of a ﬂuorescent peptide substrate as part
of a high-throughput assay identiﬁed monocyclin β-lactams as a
class of speciﬁc high afﬁnity inhibitors [34]. Using this more stan-
dardized approach, it may be possible to better assess the differential
inﬂuence of inhibitors on various rhomboids.
Recent crystal structures of ecGlpG in complex with inhibitors
have provided crucial information regarding intermediates in the
catalytic cycle of rhomboid proteases [14,16,17]. The coumarin family
of serine protease inhibitors operates by a covalent interaction with
the catalytic serine to irreversibly form an acyl or an alkylated enzyme
coupled with opening of the coumarin ring [32]. The membranedomain of ecGlpG was soaked with a coumarin-type inhibitor
(7-amino-4-chloro-3-methoxy-isocoumarin) where the resultant
structure formed a covalent acyl enzyme that has provided mechanis-
tic details of rhomboid catalysis [14]. The courmarin ring formed a
covalent bond with the nucleophilic Ser201 facilitating a covalent
interaction of the open ring with His254. Despite being an acyl-
enzyme structure during peptide bond hydrolysis, it is not typical for
the general base to bond to the peptide, thus the structure is not
truly representative of substrate interaction with the active site.
Tetrahedral intermediates in the rhomboid active site have also
been observed from soaking with the mechanistic inhibitors
diisopropylﬂuorophosphonate [16] and Cbz-Alap(O-iPr)F (CAPF),
[17]. Contrary to the coumarin inhibitor, both ﬂuorophosphonate
inhibitor structures displayed a single bond to the catalytic serine.
Inhibitor binding resulted in subtle changes for several residues
in the rhomboid active site. The GlpG-CAPF structure exhibited a
90° rotation of the general base, His254, which resulted in a hydrogen
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residues at the base of the active site (Tyr205 and Trp236). Global
movements for all three inhibitor complexes comprise movements
in the L5 cap and the top of helix 5 as well as small movements in
TM helices 1, 2, 3 and L1, suggesting these could be a global mecha-
nism for structural changes occurring during substrate gating (see
Section 4 below) [14,16,17].
The above inhibitor crystal structures importantly conﬁrmed the
location of the oxyanion hole (Fig. 3). The structures identiﬁed key
residues suspected of participating in the oxyanion hole: backbone
amides from the nucleophile Ser201 and Lys200, side chain amide
from Asn154 and the Nε of the imidazole ring of His150. This is very
complex coordination compared to soluble serine proteases. For tryp-
sin and chymotrypsin (clan PA(S)), the oxyanion is stabilized by the
main chain amides from the catalytic serine and a neighboring
glycine [27]. However for subtilisin (clan SB) the oxyanion hole is
comprised of backbone amides as well as a side chain amide from a
conserved Asn residue [35].
The various inhibitor complexes can also provide clues to the
orientation of attack by the nucleophilic serine, an important param-
eter when considering inhibitor design. For example with SPaseI, an
enzyme with a Ser-His/Lys catalytic dyad, nucleophilic attack is
thought to occur on a si-face instead of the traditional re-face [36].
The coumarin soaked crystal structure demonstrates a si-face attack
that is also visualized by a manually predicted substrate complex
with the rhomboid protease [14]. In contrast, the CAPF soaked crystalFig. 3. Peptidyl inhibitor CAFP-ecGlpG co-crystal provides evidence for substrate gating and
catalytic serine, which extends under loop 5 (cap, red) between helix 2 (cyan) and helix
oxyanion hole hydrogen bonding network from the CAFP inhibitor co-crystal structure.structure indicates a re-face attack, however the peptidyl moiety of
the inhibitor is arranged in the opposite orientation compared to
the position that a type I membrane protein substrate would have
to take in the active site with its N-terminus in the S′ position, [17].
To rationalize these apparent contradictory ﬁndings, further peptide
based inhibitor structures, or ideally a substrate co-crystal structure
is required to precisely address this question.
Overall, the advancements made using mechanistic based inhibi-
tors to study kinetics or the function of rhomboid have provided evi-
dence that despite separate evolution and a catalytic dyad instead of a
triad, this intramembrane protease class is remarkably similar to the
soluble serine protease mechanistically. Nonetheless we are still lack-
ing structural data with a rhomboid substrate or peptide substrate to
provide the necessary insight into how transmembrane peptides are
cleaved.
4. Substrate gating controversy
The active site of GlpG lies at the bottom of a solvent accessible
cavity facing the extracellular side of the membrane (Fig. 1). The
hydrophilic cavity was blocked by Loop 5 (L5) in GlpG thus restricting
substrate access (Fig. 1) [9]. Clearly for catalysis to occur the substrate
must interact with the active site, and some element(s) must be
mobile to permit substrate entry. There are two competing hypothe-
ses to explain how substrate can access the active site, which differ
fundamentally in the mechanism of how the substrate docks withoxyanion hole. (A) Cross-eyed stereo view of the CAFP inhibitor covalently bound to the
5 (blue). CAFP, magenta. Catalytic residues, green. (B) Cross-eyed stereo view of the
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mational changes in L5 are needed to permit substrate docking
from the top of the enzyme [12], while the “TM5 lateral gate
model” suggests that TM5 and L5 are mobile, with TM5 acting as a
lateral substrate gate with the substrate [20,22]. Both models have
experimental support from a combination of structural and enzy-
matic studies, thus the identity of the substrate gate remains a
contentious issue.
4.1. TM5 as a lateral substrate gate
An early crystal structure of ecGlpG was solved with two mole-
cules in the asymmetric unit, with one displaying an “open” type of
conformation with TM5 being bent away from the helical bundle
(Fig. 4). This structure led to the hypothesis that TM5 was a mobile
substrate gate whereby TM substrates could diffuse laterally into
the enzyme's active site [10]. In support of this model the crystal
structure of hiGlpG showed high B-factors in TM5 in one structure,
and completely disordered TM5 in a second structure [18,19]. Bio-
chemical evidence further supports the role of TM5 as a substrate
gate whereby mutations that disrupt interactions between TM5 and
TM2, displaced the gate away from the helical bundle and enhanced
the activity of the enzyme [22,37]. The introduction of disulﬁde
bonds to cross-link TM5 and TM2 inhibited ecGlpG activity of GlpG,
while reduction of the cross-linked disulﬁde bonds restored activity
[22]. Recently it was shown that one of these cross-linked residues
(Trp236) may be important for inhibitor docking to the active site
pointing to a potential role in substrate docking, thus complicatingFig. 4. Dynamic motion in ecGlpG and substrate access. (A) Structural basis for the putative
ID: 2IC8) overlayed with open (yellow) conformation of ecGlpG (PDB ID: 2NRF) where TM
substrate gate. (B) Top view of the ecGlpG active site displaying how the movement of TM5
access of substrate to the catalytic residues, His254 and Ser201. (C) Structural evidence for
bound structures (PDB ID: 3TXT, 2XOW, 3UBB) exhibits dynamic motion in the L5 cap (redinterpretation of these results [17]. Clearly, a series of dynamic pro-
cesses govern rhomboid substrate recognition with conformational
changes being essential for substrate binding. Recent biophysical
studies on rhomboid dynamics have demonstrated the inherent
mobility of TM5 and L5, lending credence to the hypothesis that
TM5 could act as a substrate gate. Molecular dynamics simulations
of “open” and “closed” conformations of ecGlpG in lipids indicated
that TM5 was highly dynamic in nature; however, no transition struc-
ture between the open and closed states could be observed [38]. The
dynamic nature of TM5 is furthermore buoyed by global analysis of
ecGlpG thermal stability illustrating that TM5 and nearby loops
were not important for structure but rather function solely, as a
mobile substrate gate [39]. Evidence for the dynamic nature of the
putative TM5 lateral substrate gate was also derived from EPR spec-
troscopic studies. Nitroxide spin labels introduced into positions on
TM5 and the L5 cap monitored mobility in both detergent and in lipo-
somes. Two spectral populations were observed in detergent for TM5
and the L5 cap, corresponding to “open” and “closed” conformations
indicating these regions were dynamic parts of rhomboid struc-
ture [40]. Interestingly, when the protein was reconstituted into
proteoliposomes the L5 cap remained mobile, while TM5 became
more rigid, being locked into the closed conformation. This observa-
tion suggests that TM5 is in a “closed” state in the membrane, and
led to the hypothesis that restriction of gate dynamics confers
substrate cleavage site speciﬁcity [40]. This line of inquiry represents
a signiﬁcant understanding of rhomboid activity in a lipid bilayer and
indeed further studies in proteoliposomes are needed to assess the
nature of these elements under native conditions of the bilayer.lateral substrate gate. The structure of the closed (white) conformation of ecGlpG (PDB
5 has bent away from the helical bundle, leading to the hypothesis that it is a lateral
from a closed conformation (white) to an open conformation (yellow) would permit
the L5 cap providing access of substrate to the active site. Overlay of ecGlpG inhibitor
) but little evidence for motion in TM5 (blue).
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An alternative candidate for a substrate gate is the L5 loop that in
some structures is directly blocking access to the active site. It has
been proposed that the L5 loop is the only mobile element in the
structure capable of providing the requisite structural plasticity for
substrate access to the active site [12]. Structural evidence also
supports this hypothesis; the determination of many different ecGlpG
structures (Table 1) indicate that the L5 cap region is a ﬂexible
element capable of adopting multiple conformations or being disor-
dered within the structure, although as discussed below there is a
major caveat associated with the interpretation of this structural
data (Fig. 4) [12,14–17]. To date, no crystal structures of a substrate
complex have been determined, however, three structures of ecGlpG
in complex with inhibitors provide glimpses into possible structural
rearrangements associated with ligand binding [14,16,17]. In all
three structures the L5 cap lifts out of the active site, with only
small motions associated with TM5 (Fig. 4), thus supporting the
notion that the L5 cap is primarily responsible for substrate entry
[14,16,17]. The structure of ecGlpG in complex with an isocoumarin
inhibitor resulted in a ordered L5 cap that was displaced from the
active site residues with only a small (~1.25 Å) displacement of
TM5 being observed, signiﬁcantly less than what was seen in the
supposed “open” conformation of ecGlpG [14]. Similar to the
isocoumarin structure, the crystal structure of ecGlpG in complex with
a ﬂuorophosphonate inhibitor again found only small conformational
changes within the protein, with the L5 cap region being partially
disordered and a slight tilt of TM5 toward TM6 [16]. Isocoumarin and
the ﬂuorophosphonate inhibitor are relatively small compounds, how-
ever, a third inhibitor structure with Cbz-AlaP(O-iPr)F (CAPF), a much
larger compound, better approximates the interactionwith real peptide
substrate (Fig. 3) [17]. This noteworthy structure revealed only minor
conformational changes associated with inhibitor binding, similar to
the other inhibitor structures [17]. However, due to its elongated
nature, the bound inhibitor extends from the active site between TM2
and TM5 just under the cap (L5), a few angstroms below themembrane
boundary on the extracellular face (Fig. 2A), a conformation that
perhaps more closely approximates a native substrate. The structural
data gleaned from inhibitor structures appears to conﬁrm a model
supporting both hypotheses above whereby lifting of the L5 cap, com-
bined with small changes in TM5, creates a gap between TM5 and
TM2 where TM substrates would pass to gain access to the active site.
One major caveat for the structural evidence supporting the cap
model of substrate entry is that all of the inhibitor bound crystal struc-
tures were solved in the same space group (Table 1, space group R32),
which has tight packing interactions around TM5. As the inhibitors
were soaked into the crystals, the tight packing around TM5 may have
prevented any motion of the helix that could potentially be associated
with substrate binding. Interestingly, soaking of DMSO alone triggered
motion of the L5 cap in one crystal structure [12], further raising the
possibility that the mobility of L5 could have been triggered by the
soaking process rather than the inhibitors per se. A clear resolution of
the gating controversy awaits the determination of the structure of a
substrate-bound rhomboid, a task that has proven to be elusive and
challenging.
5. Determinants of substrate speciﬁcity
Of particular challenge is that the native substrates of many rhom-
boids are as yet unknown. As rhomboids are proteases, the structural
or sequence features that determine substrate speciﬁcity are crucial
for a complete understanding catalysis. Rhomboids can readily be
identiﬁed by sequence features alone, with thousands of rhomboid
genes having been annotated in sequence databases [5,8], yet sub-
strates for only a handful of rhomboids have been identiﬁed [2,6].
This is especially true amongst prokaryotic rhomboids, where thesubstrate for only a single rhomboid has been established; the
rhomboid AarA from Provedencia stuartii is involved in quorum
sensing by cleaving TatA, a component of the twin-arginine
translocase [41,42]. Of particular note, is that the substrate for
ecGlpG, the model rhomboid and subject of intense structural,
biophysical and enzymatic research has yet to be identiﬁed. Surpris-
ingly, even evolutionarily divergent rhomboids can be functionally
exchanged for each other [43–45]. This remarkable functional
cross-reactivity between rhomboids is indicative of a highly con-
served mechanism of substrate recognition and proteolysis. Recent
work has illuminated many of the conserved features that deﬁne
rhomboid substrate speciﬁcity.
5.1. Sequence and structure features of rhomboid protease substrates
Rhomboid substrates are typically single pass Type I membrane
proteins with proteolysis occurring within the TM helix or very close
to the membrane–solute boundary. The ﬁrst rhomboid-substrate(s)
pairings to be characterized was Rhomboid-1 from Drosophila where
it was established that the protease speciﬁcally cleaves EGFR ligand
substrates Spitz, Gurken and Keren, [46]. Helices generally represent
very poor substrates for proteases [47], leading to the hypothesis
that rhomboid substrates contain helix destabilizing residues that
would permit unfolding of the helix and subsequent cleavage of the
peptide bond within the active site of the enzyme. Support for this
hypothesis was found in mutational studies examining the ability of
bothDrosophila Rhomboid-1 and ecGlpG to cleave chimeric substrates
[48,49]. Although helix-destabilizing residues are central in substrate
proteolysis, there also appears to be a sequence speciﬁc motif that is
imperative for deﬁning rhomboid substrates. Foundational work on
the sequence requirements for substrate cleavage by ecGlpG was
conducted by Akiyama's group which indicated that the residues
immediately ﬂanking both sides of the scissile bond (positions P1
and P1′ by protease substrate nomenclature), were essential for sub-
strate recognition, with a preference for negatively charged residues
at the P1 position and small side chains at the P1′ position [49]. In a
comprehensive mutagenesis study, Strisovsky, Sharpe & Freeman
[50] dissected AarA cleavage of its substrate TatA revealing speciﬁc
features adjacent to the site of proteolysis including a small side
chain at P1, a large hydrophobic residue at P4 and a hydrophobic res-
idue of indiscriminant size at position P2′ [50] complementing previ-
ous studies [49]. This apparent recognition motif was observed in
other known natural rhomboid substrates including, Gurken, Spitz
and the artiﬁcial non-natural substrate LacY TM2; furthermore, the
substrate recognitionmotif was cleaved by other rhomboids including
GlpG, YqgP and Rhomboid-1. The structural basis for this substrate
discrimination has been partially revealed by the recent crystal struc-
ture of GlpG in complex with an isocoumarin inhibitor, whereby two
cavities adjacent to the inhibitor were identiﬁed as being the S1 and
S1′ subsites (the sites where the P1 and P1′ residues on the substrate
bind to the enzyme) [14]. The sequence restriction on the substrate
P1 residue in the having a small side chain could be rationalized by
the depth and polarity of the proposed S1 cavity [14]. Interestingly
there appears to be no structural rational for the observed sequence
speciﬁcities at the P1′, P2′, and P4 positions, raising the possibility
that substrate discrimination may not be a truly sequence based
mechanisms but rather a more complex peptide property based
mechanism. However, although this substrate recognition motif
appears to be an important element in rhomboid catalyzed prote-
olysis, it does not appear to a completely universal motif, and alterna-
tively, the biophysical properties of the substrate have been
proposed to be more important. Not all rhomboids may make use
of the recognition motif, for example, of the two rhomboids found
in Mycobacterium tuberculosis, only one can complement an AarA
knockout, suggesting differences in substrate recognition [45]. As is
discussed later in this review, the cytoplasmic domains of some
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and different families of rhomboids may also make use of different
substrate requirements. Mitochondrial rhomboids such as PARL
appear to have very different substrate requirements compared to
GlpG and AarA. Many rhomboids do not have a preference for
charged residues in their substrates [50] however PARL appears
to be unique in that a region of negatively charged residues
C-terminal to the cleavage site was for needed for full activity of
the proteases, pointing to perhaps unique substrate requirements
for mitochondrial rhomboids [51].
An alterative model for ecGlpG substrate recognition has been
proposed, whereby sequence considerations are less important than
the intrinsic properties of substrates in the lipid bilayer [40]. The
authors propose that rhomboids employ a unique strategy to discrim-
inate substrates. Rather than recognizing a speciﬁc sequence the
protease exploits the tendency of the membrane to stabilize the heli-
cal structure of some TM helices, which become unwound when they
leave the membrane. Thus when the substrates exit the membrane
(by entering the active site) they unravel making them susceptible
to proteolysis [40].5.2. Two models for substrate–rhomboid interaction recognition
The difference in opinion regarding the nature of the substrate
gate and the importance of sequence speciﬁc interactions of the
substrate with rhomboid leads to two slightly different models
for substrate–rhomboid interaction. Both models have similarities
in that they require an unfolded helical substrate to access a
guarded active site, but the models differ in ﬁne details. The initial
interaction of rhomboid with substrate may not occur at a single
site on the protein, but rather may occur at multiple sites on
rhomboid and be driven largely by electrostatic interactions [52].
Rhomboid substrates can be cleaved within their TM domains,
just above the TM at the interface between the membrane and
solvent [53,54].
To account for these observations, and the structural evidence that
only the L5 cap restricts substrate access to the active site, has led to a
“top interaction” type of model. In this model, substrates interact
with the top of rhomboid through speciﬁc subsites that meet the
substrate sequence requirements that have been identiﬁed [50]. The
mobile L5 cap is displaced, and the substrate can enter the active
site where proteolysis occurs. If the substrate is cleaved in the TM
domain, helix breaking residues may be important for localized
unfolding of the helix, and protein induced compression of the mem-
brane by ecGlpG may also facilitate helix unfolding and substrate
cleavage [13,50,55]. When the substrate is cleaved above the TM
region, the requirement for helix breaking residues is not as stringent,
as the sequence may not be helical and thus more susceptible to
proteolysis [50].
The second model of rhomboid-substrate interaction relies on
the presence of the lateral TM5 gate, and the tendency of rhomboid
substrates to unwind as they exit the membrane [20,21,40]. In this
model membrane substrates enter into the active site through the
lateral TM5 gate where, if they have a propensity to unwind with-
out the lipid bilayer, they will become susceptible to proteolysis.
Furthermore, the observation that the lateral gate is mostly found
in the closed position in the membrane [40] indicates that it acts
as a further regulatory mechanism to prevent non-speciﬁc proteol-
ysis of membrane proteins. Both of these models have advantages
to rhomboid behavior, and both models are consistent with ob-
served conformations in crystal structures. The issue of which
model is correct will likely not be satisfactorily resolved until a
crystal structure of rhomboid in complex with a peptide substrate
has been determined, a task which has remained an unresolved
challenge.6. Structure and function of extra-membranous domains
While the majority of rhomboid research has focused on the struc-
ture and function of the protease containing membrane domain,
there is increasing interest in the extra-membranous domains of
rhomboids. A large number of both prokaryotic and eukaryotic rhom-
boids contain accessory domains at either the N- or C-terminal ends
of the membrane-spanning rhomboid cores. The structural basis for
the substrate speciﬁcity of rhomboids is not entirely clear; and it
may be that the soluble accessory domains associated with many
rhomboids provide either substrate speciﬁcity, or perform a crucial
regulatory role.
The types of rhomboid extra-membranous domains that have been
annotated in sequence databases are highly diverse, and inmany cases
provide clues to the function of speciﬁc rhomboids that have yet to be
characterized. Examples of accessory domains that have been anno-
tated but have yet to be experimentally characterized include
7-bladed beta propeller lactonase domains, tetra-trico-peptide repeat
(TPR) domains, zinc ﬁngers, EF hand domains, ubiquitin associated
domains (UBA), and domains of unknown function (DUF) such as
DUF3582 and DUF2156. The putative nature of many of these domains
would seem to indicate responsibility for directing rhomboid protease
to their respective substrates. For example TPR domains are found in
rhomboids from a variety Gram-positive bacteria, and these motifs
are commonly used in protein–protein interactions and the formation
of multi-protein complexes [56], hinting at a responsibility in sub-
strate targeting. Several plant rhomboids from Arabidopsis, rice,
grape vine amongst others, contain a C-terminal ubiquitin associated
domain (UBA) [57]. UBA domains are α-helical bundles that bind
ubiquitin, or most frequently polyubiquitin [58], indicating a potential
role in intracellular sorting or protein degradation. In addition, recent
work has highlighted structure–function relationships of accessory
domains associated with several eukaryotic rhomboids, and the cyto-
plasmic domain of ecGlpG pointing to their crucial role in rhomboid
function.
6.1. Structure and function of eukaryotic rhomboid extra-membranous
domains
Rhomboid extra-membranous domains are thought to be critical
for enzyme localization, a function that has been demonstrated in
several eukaryotic rhomboids and has downstream the effect of
regulating accessibility to substrates. One key mechanism of regulat-
ing rhomboid function in eukaryotes is through tight control of the
subcellular compartmentalization of the enzyme and substrates in
various membranes within the cell. This indirect means of regulation
has been found to be a primary mechanism in Drosophila rhomboid-1
and its processing of EGFR ligands [59–62]. The soluble N-terminal
domains found in the rhomboids TgRom1 and TgRom2 of the
apicomplexan parasite Toxoplasma gondii have been shown to contain
determinants for protein trafﬁcking [63]. Other recent work has re-
vealed an intriguing case for soluble domains acting as exosites for
interaction with substrates, thereby providing a substrate–rhomboid
interaction regulation point. The eukaryotic rhomboid RHBDL4 is an
ER-associated rhomboid that is involved in the ER-associated degra-
dation (ERAD) pathway for misfolded proteins. The C-terminal do-
main of RHBDL4 contains a ubiquitin interacting motif (UIM) that is
required for RHBDL4-mediated degradation of both single-spanning
and polytopic ubiquitinated membrane proteins with positively
charged TM residues [64]. A similar role in substrate binding has
been found for rhomboid RHBDL2 where the cytoplasmic domain is
important for substrate (thromobomodulin) cleavage [65]
In eukaryotes the cytoplasmic portions of rhomboids are capable of
mediating important events in the regulation of rhomboid proteolysis.
In general however, examination of the sequences of the rhomboid
TgROM1, TgROM2, and RHDBL4 reveals that the cytosolic domains
Fig. 5. Structures of ecGlpG cytoplasmic domains (DUF3582). (A) Solution NMR struc-
ture of paGlpG cytoplasmic domain (PDB ID: 2GQC). (B) Solution NMR of ecGlpG
cytoplasmic domain (PDB ID:2LEP) shows a more compact globular structure than
the paGlpG structure. (C) X-ray structure of ecGlpG reveals a domain swapped dimer
(teal and yellow) (PDB ID: 4HDD).
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likely be highly mobile, and in their full-length form may not be
amenable to X-ray crystallography [66]. The functional motifs attrib-
uted to the function of this domain therefore may be relatively small
peptides found in a largely disordered region. Intrinsically disordered
proteins are known to play key roles inmolecular recognition [67]. For
example UIM motifs (in RHBDL4) are typically unable to form inde-
pendent folding domains, but rather are simply short α-helices capa-
ble of binding ubiquitin [68]. Prokaryotes on the other hand, contain
well-ordered, globular cytosolic domains that are amenable to
structure studies [25].
6.2. Structure and function of the prokaryotic GlpG rhomboid domain
DUF3582
The archetype rhomboid ecGlpG contains an N-terminal cytoplas-
mic domain of approximately 90 residues (DUF3582) and is found
only in bacterial rhomboids, primarily in the class Gammaproteo-
bacteria. A cursory examination of available annotated rhomboid
sequences from Gammaproteobacteria in the Pfam protein families
database [69] reveals that approximately 3/5 of the sequences contain
the domain. Thus despite the domain's wide distribution, it is not abso-
lutely required for in vivo function of GlpG in all bacteria. No crystal
structure has been solved for any full-length rhomboid that includes
both its soluble domain and core membrane domain. In order to obtain
well diffracting crystals of ecGlpG the cytoplasmic domain had to be
removed through proteolysis [9–11].
The ﬁrst rhomboid accessory domains structurally characterized
were the cytoplasmic domains from Pseudomonas aeruginosa GlpG
(paGlpG) and ecGlpG. The structure of both paGlpG and ecGlpG
were determined by solution NMR [23,24] followed by a high resolu-
tion X-ray structure of ecGlpG [25] (Fig. 5), (Table 1). The solution
NMR structure of the paGlpG cytoplasmic domain revealed a mixed
α/β fold composed of a three-stranded anti-parallel β-sheet and
two α-helices (Fig. 4A) [23]. In comparison, globular ecGlpG cytoplas-
mic domain was signiﬁcantly different from the paGlpG structure,
with extensive interactions being formed between the α-helices
and β-sheet and different positioning of the α-helices (Fig. 5B). The
X-ray structure of the ecGlpG cytoplasmic domain revealed another
surprise, as the structure was found not monomeric, but rather as a
dimer that contained extensive domain sharing between monomers,
resulting in a rather elongated fold which differs substantially from
the NMR structure [25] (Fig. 5C). Furthermore, dimers could be isolated
from the full-length protein suggesting the structure is physiologically
relevant [25]. These structures combined with kinetic and functional
studies have begun to unravel the role of this domain in rhomboid func-
tion, while raising new questions worthy of further investigation.
The NMR structure of the paGlpG cytoplasmic domain displayed
distant structural homology to the N-terminal domain of EscJ, a com-
ponent of the type III secretion system, and a protein involved in
localization to the cytoplasmic membrane. This weak structural
homology led to the initial suggestion that the cytoplasmic domain
of rhomboid may interact with the lipid bilayer. This interaction
was hypothesized to be important in correct positioning of the active
site for efﬁcient cleavage of substrate [23]. Consistent with this was
the observation that the domain interacts with phosphocholine
containing micelles [23]. Although the interaction of the membrane
domain with the lipid bilayer is an attractive model to explain the
catalytic effects of the cytoplasmic domain, further NMR and func-
tional investigation revealed that the cytoplasmic domain did not
interact with liposomes or large unilamellar vesicles composed of E.
coli lipids, indicating that the cytoplasmic domain could not in fact
interact with native membranes [70]. Furthermore, examination
of NMR spectra from the cytoplasmic domain interacting with
phosphocholine detergent micelles was suggestive of a denaturing
interaction rather than a binding interaction [70]. NMR of full-lengthpaGlpG resulted in resonances from only the cytosolic domain, and
just in detergents that inactivated rhomboid activity. The NMR signal
from the cytosolic domain disappeared when the rhomboid was
placed in detergents that resulted in high levels of rhomboid activity,
leading to the proposal that the domain was interacting with a
different part of the rhomboid, and inﬂuencing its activity in a direct
manner [70].
Recent detailed kinetic analyses of the ecGlpG using a ﬂuorescent
substrate assay have unveiled surprising facts regarding the function
and role of the cytoplasmic domain [25]. Proteolytic removal of the
cytoplasmic domain from ecGlpG resulted in identical Kcat and Vmax
values for the rhomboid compared to the intact protein, clearly show-
ing that contrary to earlier observations [9], the cytoplasmic domain
does not play a direct role in inﬂuencing substrate catalysis. Similar
conclusions were obtained using an activity based probe [24]. Since
the cytoplasmic domain does not directly inﬂuence GlpG activity,
the question remains what is the role of this domain.
The observed domain swapped dimer of the ecGlpG cytoplasmic
domain in the X-ray structure (Fig. 4C) points to another possible
role for the cytoplasmic domain in rhomboid structure–function.
There is some recent evidence that rhomboids from E. coli, H.
inﬂuenzae and B. subtilis all possibly exist as dimers in vivo in the
membrane [71]. The functional consequences of rhomboid dimeriza-
tion are unclear, however it is tempting to speculate that it may pro-
vide some role in oligomerization or regulation of enzyme function.
Furthermore, the domain swapped dimer of the cytoplasmic domain
creates a new and unique surface that may either facilitate dimeriza-
tion of the protein, or perhaps expose a new exosite for substrate
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remain a challenging task to fully unravel the functional role of the
cytoplasmic domain. A complete understanding of the relationship
between the rhomboid core membrane domain and the cytoplasmic
domain would be revealed by determination of a crystal structure
or the intact protein, which to date has proven to represent a major
challenge.
7. Future perspectives
The recent abundance of structural and functional studies on
rhomboid has greatly advanced our understanding of many aspects
of rhomboid structure and function. Yet there is still much to be
understood for this interesting class of enzymes. To date, only one
rhomboid topology, 6TM, has been described structurally, with the
differences in the 1 + 6TMand 6 + 1TM classes remaining amystery.
We have a preliminary glimpse of the structures for the cytoplasmic
domain of the E. coli and P. aeruginosa rhomboid, but there are other
interesting domains to be studied, including the effects of oligomeri-
zation. Lastly, a great deal of information could be gained from addi-
tional inhibitor-enzyme crystal structures, in particular peptide-
based inhibitors. However despite the advances in understanding
offered by the inhibitor structures, the degree to which they represent
the state of the enzyme-substrate complex remains to be seen. Clearly
the enzyme will have considerably more interactions with the
substrate compared to the inhibitor, thus care must be taken in the
interpretation of these structures. A substrate crystallized with a
rhomboid enzyme would answer many of the remaining controver-
sies surrounding the catalytic mechanism, the basis of substrate
speciﬁcity and discrimination as well as the nature of the substrate
gate and substrate speciﬁcity.
Another area of future research lies in obtaining a better under-
standing of how the membrane environment inﬂuences the catalytic
activity of rhomboid. It is clear that lipids and the membrane inﬂu-
ence the activity of rhomboid [33,40,55], there are still a many
unaddressed questions in this area including how the shape and com-
position of the membrane inﬂuences the energetics of the reaction
and a deeper understanding of the interaction of substrate with the
bilayer and the inﬂuence on activity. There are many exciting areas
of research to be explored in the ﬁeld of rhomboid proteases, and
the coming years will no doubt yield many new insights into the
structure–function relationship of this important class of protein.
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